Resultados de la ablación con catéter con mínimo o nulo empleo de fluoroscopia en pacientes pediátricos con taquiarritmias supraventriculares / Results of catheter ablation with zero or near zero fluoroscopy in pediatric patients with supraventricular tachyarrhythmias

Introducción y objetivos: La exposición a radiación ionizante en los procedimientos de ablación conlleva riesgos para la salud, sobre todo en pacientes pediátricos. Nuestro objetivo es comparar la seguridad y la eficacia de la ablación guiada por un sistema de navegación intracardiaca no fluoroscópica (SNINF) con las de la ablación guiada exclusivamente por fluoroscopia en pacientes pediátricos. Métodos: Se analizaron los resultados de la ablación con catéter en pacientes pediátricos con vías accesorias de riesgo o taquicardias supraventriculares remitidos a nuestro centro en un periodo de 6 años. Se compararon los procedimientos guiados solo por fluoroscopia (grupo A) y los guiados por SNINF (grupo B). Resultados: Se analizaron 120 procedimientos de ablación en 110 pacientes (edad, 11±3,2 años; el 70% varones), 62 procedimientos en el grupo A y 58 en el grupo B. No se encontraron diferencias significativas entre ambos grupos en éxito del procedimiento (el 95% del grupo A y el 93,5% del grupo B; p=0,53), complicaciones (el 1,7 frente al 1,6%; p=0,23) y recurrencia (el 7,3 frente al 6,9%; p=0,61). Sin embargo, el tiempo de fluoroscopia (mediana, 1,1 frente a 12 min; p<0,0005) y el tiempo de ablación (mediana, 96,5 frente a 133,5 s; p=0,03) fueron menores en el grupo B. La presencia de cardiopatía se comportó como un predictor independiente de recurrencia (p=0,03). Conclusiones: El SNINF para guiar los procedimientos de ablación en pacientes pediátricos reduce el tiempo de exposición a la radiación ionizante. Su empleo generalizado en las ablaciones pediátricas podría reducir el riesgo atribuido a la radiación (AU)

Introduction and objectives: Ionizing radiation exposure in catheter ablation procedures carries health risks, especially in pediatric patients. Our aim was to compare the safety and efficacy of catheter ablation guided by a nonfluoroscopic intracardiac navigation system (NFINS) with those of an exclusively fluoroscopy-guided approach in pediatric patients. Methods: We analyzed catheter ablation results in pediatric patients with high-risk accessory pathways or supraventricular tachycardia referred to our center during a 6-year period. We compared fluoroscopy-guided procedures (group A) with NFINS guided procedures (group B). Results: We analyzed 120 catheter ablation procedures in 110 pediatric patients (11±3.2 years, 70% male); there were 62 procedures in group A and 58 in group B. We found no significant differences between the 2 groups in procedure success (95% group A vs 93.5% group B; P=.53), complications (1.7% vs 1.6%; P=.23), or recurrences (7.3% vs 6.9%; P = .61). However, fluoroscopy time (median 1.1minutes vs 12minutes; P <.0005) and ablation time (median 96.5seconds vs 133.5seconds; P=.03) were lower in group B. The presence of structural heart disease was independently associated with recurrence (P=.03). Conclusions: The use of NFINS to guide catheter ablation procedures in pediatric patients reduces radiation exposure time. Its widespread use in pediatric ablations could decrease the risk of ionizing radiation (AU)

Morbimortalidad de la endocarditis aguda por Streptococcus agalactiae / Morbimortality of acute endocarditis caused by Streptococcus agalactiae

Introducción. El Streptococcus agalactiae es un agente causal infrecuente de endocarditis aguda. Suele afectar a pacientes con patología de base y tiene un mal pronóstico. Material y métodos. Estudio retrospectivo que compara las características clínicas de5 casos de endocarditis aguda por Streptococcus agalactiae atendidos en nuestro Hospital, en los últimos doce años, con 43 endocarditis producidas por otros microorganismos. Analizamos como variables dependientes el tamaño de la vegetación, la necesidad de cirugía, el desarrollo de complicaciones, el tiempo de hospitalización y la mortalidad global. Resultados. Todos los casos de endocarditis por estreptococo del grupo B (SGB) tenían mayor tamaño de la vegetación, todos requirieron cirugía y tuvieron estancias hospitalarias prolongadas y mortalidad del 40%, todo ello superior a las endocarditis por otros microorganismos. Conclusión. La endocarditis aguda por Streptococcus agalactiae es un cuadro grave que requiere cirugía precoz en su tratamiento, presenta mortalidad elevada, tasa alta de complicaciones y estancias hospitalarias prolongadas (AU)

Introduction. Streptococcus agalactiae is an uncommon cause of acute endocarditis. It is more likely to occur in people with underlying diseases and usually evolves poorly. Materials and methods. We have conducted a retrospective study comparing the clinical features of Streptococcus agalactiae acute endocarditis attended in our Hospital during the last twelve years with the ones caused by other microorganisms; we have analized as dependent variables the vegetation size, surgery needing, complications, time of hospitalisation and global mortality. Results. All the cases by SGB had a great vegetation size, all needed surgery in its management with long hospitalisation periods, and the mortility was of 40%; everything was higher than other microorganism’s endocarditis. Conclusion. Streptococcus agalactiae acute endocarditis is a serious disease which requires early surgery in its management. Its mortality rate, complications and hospitalisation time are high (AU)

[Morbimortality of acute endocarditis caused by Streptococcus agalactiae]. / Morbimortalidad de la endocarditis aguda por Streptococcus agalactiae.

INTRODUCTION: Streptococcus agalactiae is an uncommon cause of acute endocarditis. It is more likely to occur in people with underlying diseases and usually evolves poorly. MATERIALS AND METHODS: We have conducted a retrospective study comparing the clinical features of Streptococcus agalactiae acute endocarditis attended in our Hospital during the last twelve years with the ones caused by other microorganisms; we have analized as dependent variables the vegetation size, surgery needing, complications, time of hospitalisation and global mortality. RESULTS: All the cases by SGB had a great vegetation size, all needed surgery in its management with long hospitalisation periods, and the mortility was of 40%; everything was higher than other microorganism's endocarditis. CONCLUSION. Streptococcus agalactiae acute endocarditis is a serious disease which requires early surgery in its management. Its mortality rate, complications and hospitalisation time are high.

Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain.

The aim of this cross-sectional study was to establish the frequency, phenotype and characteristics of metabolic syndrome (MS), as defined by the Adult Treatment Panel III, in a cohort of patients with systemic lupus erythematosus (SLE) and its possible association with cardiovascular diseases (CVD). A total of 160 patients with SLE and 245 age, sex, educational level and ethnically matched controls were included. Association with cardiovascular risk factors, SLE features, treatment of SLE and history of CVD were assessed in patients with SLE and controls with and without MS. MS was non-significantly increased in patients with SLE (20%) compared with controls (13%; P = 0.083). It was more commonly observed in patients with SLE < or =40 years old (15.8%) than in controls of the same age group (4.2%; P < 0.001). The mean number of MS criteria was significantly higher among patients with SLE than in controls. The frequency of CVD was also 28-fold higher among patients with SLE (11.3%) than in controls (0.4%). SLE with MS presented higher levels of inflammatory markers than SLE without MS. In a multivariate analysis, educational level, serum triglycerides, HDL-cholesterol and C3 serum levels and hydroxychloroquine use were independently associated with MS.

[Intolerance to hydroxychloroquine marketed in Spain (Dolquine) in patients with autoimmune conditions]. / Intolerancia a la hidroxicloroquina comercializada en España (Dolquine) en pacientes con patología autoinmune.

BASIS: A significant proportion of our patients has described to have problems from tolerance to Dolquine, a new presentation of hydroxychloroquine recently marketed in Spain, compared to Plaquenil. The objective was to know the tolerability and the adverse effects of this new presentation. PATIENTS AND METHOD: A cross-sectional multicenter study on 133 patients treated with Dolquine was conducted. RESULTS: Of the 133 patients (87% women; average age [AA]: 32.9 [15.4] years) who received Dolquine during an average period of 6.7 (1.4) months, 32 patients (24%) described to have more problems with this drug in comparison with other antimalarial. The adverse effects experienced were: bitter taste (62.4%), difficulty in swallowing the tablet (13.5%), dyspepsia (9.8%), nausea (7.5%), vomiting (1.5%), pruritus (1.5%), diarrhea (0.7%), and instability feeling (0.7%). The presence of gastrointestinal adverse effects was not related to the consumption of gastroerosive drugs, gastric protectors, or a high number of drugs. The attrition rate was 9.8%. Conclusions. Dolquine induces lower tolerance and more gastrointestinal adverse effects than Plaquenil, pointing out its bitter taste and the difficulty in swallowing it. Despite this higher intolerance there was not an increase in the attition rate from the antimalarial treatment in comparison to other series.